Epigenetic and Insurtech Update, Week of December 3, 2018
Cancer DNA binds to gold. That could lead to new cancer blood test
This is a truly amazing research article that provides insight into things to come! I spoke with several leading researchers on this topic and they agreed that the process/results make sense and if the results holds up – its a big deal.
Liquid biopsy detects epigenetic signature common to all cancers
Epigenetic map may pave way for new therapeutic solutions to hearing loss
Researchers find evidence of epigenetics in single-cell organisms
Natural selection in the womb: can this explain adulthood health problems?
Epigenetic insights on nutrition, hormones and eating behavior
Genomics for cryptocurrency startup Nebula Genomics lands $4.3M
Insurtech Lemonade has a pop at Europe
Commercial insurtech is like an exclusive club – and Google and Amazon aren’t invited
10 insurtech predictions for 2019
Biggest changes for insurtech for 2019
How does EverQuote make money?
A finance veteran is betting $50 million on a life insurtech in Singapore
Allianz Life Ventures partners with St. Louis-based insurtech venture fund